Matches in Wikidata for { <http://www.wikidata.org/entity/Q63400755> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q63400755 description "clinical trial" @default.
- Q63400755 description "ensayu clínicu" @default.
- Q63400755 description "klinisch onderzoek" @default.
- Q63400755 description "клінічне випробування" @default.
- Q63400755 name "Phase I/II Study of Avelumab in Pediatric Cancer Subjects" @default.
- Q63400755 type Item @default.
- Q63400755 label "Phase I/II Study of Avelumab in Pediatric Cancer Subjects" @default.
- Q63400755 prefLabel "Phase I/II Study of Avelumab in Pediatric Cancer Subjects" @default.
- Q63400755 P1050 Q63400755-1D7BFF1B-F839-474D-80F2-ED3E3B582815 @default.
- Q63400755 P1132 Q63400755-F16A9A75-0C78-4F61-B091-564D622B206F @default.
- Q63400755 P1476 Q63400755-5E04A5A4-9C6E-473B-9BFE-8D5488A69E5A @default.
- Q63400755 P17 Q63400755-22C831E4-C165-49D6-A55B-B1A979A1F153 @default.
- Q63400755 P17 Q63400755-619297F5-8C62-43DC-9E31-BDF2DBF619D3 @default.
- Q63400755 P17 Q63400755-96CBACA4-F6C5-4E90-859A-78ABF45AC4D9 @default.
- Q63400755 P17 Q63400755-B6BFD88B-E4F0-4FDA-8535-BD402E065DAF @default.
- Q63400755 P3098 Q63400755-9D5F2491-B627-4E8D-A7F9-5737495D1989 @default.
- Q63400755 P31 Q63400755-493485E5-7E0C-4B53-9B43-20A78FFFEB74 @default.
- Q63400755 P4135 Q63400755-193CBD66-AD7A-4882-926E-89FA86C1F411 @default.
- Q63400755 P580 Q63400755-A339240D-274E-44EC-A3A4-E4EE5A6E795B @default.
- Q63400755 P582 Q63400755-8B828AC0-C0F4-4059-B964-C24D9400A1B1 @default.
- Q63400755 P6099 Q63400755-69CA1F8E-2014-4E79-9A6F-FECF9CF7A6B4 @default.
- Q63400755 P6099 Q63400755-D294C447-7C9C-4CCE-B05B-DDAF04143F2D @default.
- Q63400755 P6153 Q63400755-31929CBE-BC1D-49E9-91C6-D57EDA9CC3AF @default.
- Q63400755 P6153 Q63400755-48D5C0BB-CD86-4D8C-A41E-5D056564760F @default.
- Q63400755 P6153 Q63400755-E72A8486-6F62-43FC-BCF3-AE0EE8F44CD4 @default.
- Q63400755 P6153 Q63400755-F2448051-B0C3-4787-922B-815E66D802C2 @default.
- Q63400755 P6153 Q63400755-FDB2486D-A65F-4072-922A-CFFFE336F3B1 @default.
- Q63400755 P8363 Q63400755-4B373CDD-23F0-46A7-8408-39F221D25126 @default.
- Q63400755 P1050 Q208414 @default.
- Q63400755 P1132 "+148" @default.
- Q63400755 P1476 "Open-label, Phase I/II Study to Evaluate Pharmacokinetics, Pharmacodynamics, Safety, and Anticancer Activity of Avelumab in Pediatric Subjects From Birth to Less Than 18 Years of Age With Refractory or Relapsed Solid Tumors and Lymphoma" @default.
- Q63400755 P17 Q16 @default.
- Q63400755 P17 Q30 @default.
- Q63400755 P17 Q31 @default.
- Q63400755 P17 Q35 @default.
- Q63400755 P3098 "NCT03451825" @default.
- Q63400755 P31 Q30612 @default.
- Q63400755 P4135 "+18" @default.
- Q63400755 P580 "2018-03-07T00:00:00Z" @default.
- Q63400755 P582 "2022-06-02T00:00:00Z" @default.
- Q63400755 P6099 Q42824440 @default.
- Q63400755 P6099 Q5452194 @default.
- Q63400755 P6153 Q1468161 @default.
- Q63400755 P6153 Q39988 @default.
- Q63400755 P6153 Q4403855 @default.
- Q63400755 P6153 Q624119 @default.
- Q63400755 P6153 Q833670 @default.
- Q63400755 P8363 Q78089383 @default.